Article

Modelling Lysosomal Storage Disorders in an innovative way: Establishment and Characterization of Stem Cell Lines from Human Exfoliated Deciduous Teeth of Mucopolysaccharidoses Type II Patients

2024-02-29

Abstract excerpt

Among the many Lysosomal Storage Disorders (LSDs) that would benefit from the establish-ment of novel cell models, either patient-derived or genetically engineered, is Mucopolysaccha-ridosis type II (MPS II). In fact, even though a specific therapeutic approach does exist for this disorder (Enzyme Replacement Therapy, ERT, with recombinant human IDS) and haematopoiet-ic stem cell transplantation (HSCT) may also ho...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9a0297d0-17b6-51dc-9405-e115c93e4bd8
DOI: 10.20944/preprints202402.1708.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Modelling Lysosomal Storage Disorders in an innovative way: Establishment and Characterization of Stem Cell Lines from Human Exfoliated Deciduous Teeth of Mucopolysaccharidoses Type II PatientsDOI 10.20944/preprints202402.1708.v1Read

Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New IndicationsSemantic proximity Read

Disease models for the development of therapies for lysosomal storage diseases.Semantic proximity Read

iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II.Semantic proximity Read

Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis ISemantic proximity Read

Stem Cell Therapy for the Central Nervous System in Lysosomal Storage DiseasesSemantic proximity Read

Induced pluripotent stem cell models of lysosomal storage disordersSemantic proximity Read

Neural cells generated from human induced pluripotent stem cells as a model of CNS involvement in mucopolysaccharidosis type II.Semantic proximity Read

Neurological Disease Modeling Using Pluripotent and Multipotent Stem Cells: A Key Step Towards Understanding and Treating MucopolysaccharidosesSemantic proximity Read

New Indications for Hematopoietic Stem Cell Gene Therapy in Lysosomal Storage DisordersSemantic proximity Read

Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 3-year-old male with pathogenic IDS mutation.Semantic proximity Read

Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 1-year-old male with pathogenic IDS mutation.Semantic proximity Read

The controversial and changing role of haematopoietic cell transplantation for lysosomal storage disorders: an updateSemantic proximity Read